Related Experiment Videos
Summary
Iohexol, a nonionic contrast medium, demonstrates a lower toxicity profile compared to ionic and other nonionic agents. This review highlights its biological profile for neurovascular and myelographic applications.
Area of Science:
- Radiology and Medical Imaging
- Pharmacology and Toxicology
Background:
- Contrast media are essential for medical imaging, but can cause adverse effects.
- Nonionic contrast agents offer potential safety advantages over ionic agents.
- Iohexol is a widely used nonionic contrast medium.
Purpose of the Study:
- To review the biological profile of iohexol.
- To evaluate its safety and efficacy in neurovascular and myelographic applications.
- To compare iohexol with other contrast media in animal models.
Main Methods:
- Systematic review of existing literature.
- Analysis of animal model studies.
- Comparison of iohexol with ionic and other nonionic contrast media.
Main Results:
- Iohexol exhibited lower systemic toxicity (teratogenicity, mutagenicity, embryotoxicity).
- Iohexol showed reduced cerebrovascular effects (epileptogenicity, arachnoiditis potential).
- Iohexol demonstrated a favorable safety profile compared to conventional and newer agents.
Conclusions:
- Iohexol presents a favorable biological profile for neurovascular and myelographic imaging.
- Its lower toxicity suggests improved patient safety in contrast-enhanced procedures.
- Further clinical studies may confirm these findings in human subjects.